Exploration of the Relationship of Reduction in HbA1c and Body Weight by Dapagliflozin in Patients With T2DM: Pooled Analysis of 5 Clinical Trials

被引：0
|
作者：
Hardy, Elise
Salsali, Afshin
Wessman, Catrin
Wei, Li
Mansfield, Traci
Parikh, Shamik
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
987-P
引用
收藏
页码：A252 / A252
页数：1
相关论文
共 50 条
  • [21] PREVALENCE OF ANTIPHOSPHOLIP ANTIBODY AND HBA1C IN T2DM WITH DIABETIC VASCULAR COMPLICATIONS
    Nwagha, T. U.
    Agwu, O.
    HAEMATOLOGICA, 2017, 102 : 871 - 872
  • [22] Clustering of HBA1C longitudinal trajectories in type 2 diabetes mellitus (T2DM)
    De la Torre, Adrian Martinez
    Faquetti, Maria Luisa Marques De Sa
    Perez-Cruz, Fernando
    Weiler, Stefan
    Burden, Andrea
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 60 - 60
  • [23] Dose-Response and Exposure-Response (HbA1c) of Dapagliflozin in T1DM Patients
    Parkinson, Joanna R.
    Melin, Johanna
    Astrand, Magnus
    Hamren, Bengt
    Boulton, David W.
    Tang, Weifeng
    DIABETES, 2018, 67
  • [24] The potential value of establishing a standard HbA1c value for the prevention of cognitive impairment in T2DM patients
    Zhen, Yanfeng
    Fang, Hui
    Liu, Xingyu
    Xu, Gang
    Tian, Jinli
    Li, Yukai
    Zhang, Cuilin
    Zhou, Li
    Yang, Yue
    Sun, Xueling
    Zhang, Guyue
    Zhang, He
    Xu, Jing
    Zhou, Lei
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 : 70 - 70
  • [25] Initial HbA1c and HbA1c Lowering: Implications for Model-Based Economic Evaluations in Type 2 Diabetes Mellitus (T2DM)
    Willis, Michael
    Neslusan, Cheryl
    Asseburg, Christian
    He, Jianming
    DIABETES, 2011, 60 : A68 - A68
  • [26] Based on HbA1c Analysis: Bone Mineral Density and Osteoporosis Risk in Postmenopausal Female with T2DM
    Gao, Lei
    Liu, Ying
    Li, Min
    Wang, Yan
    Zhang, Wei
    JOURNAL OF CLINICAL DENSITOMETRY, 2024, 27 (01)
  • [27] Abnormally low HbA1c in type 2 diabetes mellitus (T2DM): Familiar study
    Gargallo, Manuel A.
    Familiar, Cristina
    Gonzalez, Fernando A.
    Villegas, Ana
    DIABETES, 2006, 55 : A112 - A113
  • [28] Differentiation of basal insulins in randomized clinical trials in T2DM subjects: a model-based meta-analysis of HbA1c and hypoglycemic event rates
    Vaddady, Pavan
    Lovern, Mark
    Lommerse, Jos
    Fancourt, Craig
    Kandala, Bhargava
    Mandema, Jaap
    Gheyas, Ferdous
    Kerbusch, Thomas
    Visser, Sandra A. G.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S69 - S69
  • [29] Vildagliptin is as effective as rosiglitazone in lowering HbA1c but without weight gain in drug-naive patients with type 2 diabetes (T2DM)
    Rosenstock, Julio
    Baron, Michelle A.
    Schweizer, Anja
    Mills, David
    Dejager, Sylvie
    DIABETES, 2006, 55 : A133 - A133
  • [30] Efficacy of once-weekly dulaglutide on HbA1c reduction in East Asian patients with T2DM: subgroup analysis according to potential influencing factors
    Peng, Yongde
    Zhang, Bin
    Hou, Jianing
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35
12345